The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Gou, Wen feng ^a   Zhao, Yang ^b   Lu, Hang ^a   Yang, Xue feng ^a   Xiu, Yin ling ^b   Zhao, Shuang ^a   Liu, Jian min ^a   Zhu, Zhi tu ^a   Sun, Hong zhi ^a   Liu, Yun peng ^b   Xu, Feng ^c   Takano, Yasuo ^d   Zheng, Hua chuan ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d KANAGAWA CANCER CENTER   (Japan)

Author keywords

Epithelial to mesenchymal transition; Ovarian carcinoma; RhoC

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ALPHA SMOOTH MUSCLE ACTIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NINTEDANIB; NOTCH1 RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN 165; GUANOSINE TRIPHOSPHATASE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT VASCULOTROPIN; TRANSCRIPTION FACTOR SLUG; CADHERIN; RHOC PROTEIN, HUMAN; VASCULOTROPIN A;

ARTICLE; CAOV3 CELL LINE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; LAMELLIPODIUM; NUCLEOTIDE SEQUENCE; OVARIAN CANCER CELL LINE; OVARY CARCINOMA; OVCAR3 CELL LINE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; ALPHA SMA GENE; ANTIPROLIFERATIVE ACTIVITY; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; E CADHERIN GENE; GENE OVEREXPRESSION; GENE SILENCING; N CADHERIN GENE; NOTCH1 GENE; PLASMID; RHOC GENE; SLUG GENE; SNAIL GENE; CARCINOMA; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

CADHERINS; CARCINOMA; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMANS; OVARIAN NEOPLASMS; RHO GTP-BINDING PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903422039     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-477     Document Type: Article

References (25)

1. Menon U, Gentry-Maharaj A, Jacobs I. Ovarian cancer screening and mortality. JAMA 2011, 306(14):1544.
2. Bandera CA. Advances in the understanding of risk factors for ovarian cancer. J Reprod Med 2005, 50(5):399-406.
3. Huang RY, Chung VY, Thiery JP. Targeting pathways contributing to epithelial- mesenchymal transition (EMT) in epithelial ovarian cancer. Curr Drug Targets 2012, 13(13):1649-1653.
4. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 2010, 21(Suppl 7):vii89-vii92.
5. Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial- mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets 2010, 11(6):745-751.
6. Ouyang G, Wang Z, Fang X, Liu J, Yang CJ. Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci 2010, 67(15):2605-2618.
7. Bendris N, Arsic N, Lemmers B, Blanchard JM. Cyclin A2: Rho GTPases and EMT. Small GTPases 2012, 3(4):225-228.
8. Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 2006, 16(10):522-529.
9. Zhao Y, Zong ZH, Xu HM. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9. Gynecol Oncol 2010, 116(3):563-571.
10. Zhao Y, Zheng HC, Chen S, Gou WF, Xiao LJ, Niu ZF. The role of RhoC in ovarian epithelial carcinoma: a marker for the carcinogenesis, progression, prognosis, target therapy. Gynecol Oncol 2013, 130(3):570-578.
11. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R, Mak TW. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 2005, 19(17):1974-1979.
12. Srivastava S, Ramdass B, Nagarajan S, Rehman M, Mukherjee G, Krishna S. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. Br J Cancer 2010, 102(1):196-205.
13. Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin Exp Metastasis 2008, 25(5):569-579.
14. Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 2006, 25(52):6959-6967.
15. Li W, Murai Y, Okada E, Matsui K, Hayashi S, Horie M, Takano Y. Modified and simplified western blotting protocol: use of intermittent microwave irradiation (IMWI) and 5% skim milk to improve binding specificit y. Pathol Int 2002, 52(3):234-238.
16. Liu N, Zhang G, Bi F, Pan Y, Xue Y, Shi Y, Yao L, Zhao L, Zheng Y, Fan D. RhoC is essential for the metastasis of gastric cancer. J Mol Med (Berl) 2007, 85(10):1149-1156.
17. Islam M, Lin G, Brenner JC, Pan Q, Merajver SD, Hou Y, Kumar P, Teknos TN. RhoC expression and head and neck cancer metastasis. Mol Cancer Res 2009, 7(11):1771-1780.
18. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29(34):4741-4751.
19. Bates RC, Mercurio AM. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 2005, 4(4):365-370.
20. Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, Obrien T, Kerin MJ. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010, 124(2):317-326.
21. Mukai M, Endo H, Iwasaki T, Tatsuta M, Togawa A, Nakamura H, Inoue M. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells. Biochem Biophys Res Commun 2006, 346(1):74-82.
22. Wang W, Wu F, Fang F, Tao Y, Yang L. RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization. Cancer Sci 2008, 99(10):2012-2018.
23. Naber HP, Drabsch Y, Snaar-Jagalska BE, ten Dijke P, van Laar T. Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun 2013, 435(1):58-63.
24. Brandl M, Seidler B, Haller F, Adamski J, Schmid RM, Saur D, Schneider G. IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. J Cell Sci 2010, 123(Pt 24):4231-4239.
25. Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011, 307(1):26-36.